Here’s why it’s taken so long to develop a vaccine for respiratory syncytial virus and what we can expect next.
Academic rigor, journalistic flair
Articles on RSV
Displaying all articles
A combination of high demand and poor stock planning may explain current problems.
Evidence-based tools for dialectical behaviour therapy can help us manage family stressors during the virulent respiratory virus season.
While RSV can become severe for any child, it poses a particularly serious threat for the youngest babies and for high-risk children.
Nine children in the UK have now died from invasive group A strep. It’s important that parents know what to look out for.
As visits to emergency departments surge — and in some cases overwhelm hospitals — here are answers to frequently asked questions about Respiratory syncytial virus (RSV).
Family physicians are on the frontline of health care, and their observations and support can help us get through the upcoming winter season.
In 2020, with adult ICUs at risk of being overwhelmed, we wore masks and accepted restrictions. Now pediatric intensive care is at risk. Will leaders follow the evidence and tell us to mask up?
Respiratory syncytial virus may be common, but it can lead to severe infection in some children.
Respiratory viruses are hitting young children and infants particularly hard this fall and winter season, and experts don’t yet know exactly why.
Flu and COVID-19 are expected to make headway during the current respiratory virus season. The best way to stay healthy is vaccination in conjunction with personal protective measures.
Cases of seasonal diseases may be higher due to a lack of exposure during the pandemic. Here are four graphs which give us some clues as to how things might play out.
Tens of thousands of children have tested positive for respiratory syncytial virus in the last months in what is the largest outbreak of the virus in recent years.
Whooping cough rates are the lowest they’ve been for years. But what comes next?
As international borders open, restrictions ease and we mingle with others, we can expect more germs to circulate.
COVID restrictions have prevented the spread of other respiratory viruses too. As these are lifted, the UK government has warned parents of a delayed surge in infections
Public health measures have helped control COVID-19 in Australia. But they’ve affected other winter viruses, too.
A drug called palivizumab can keep babies infected with respiratory syncytial virus (RSV) out of the hospital, but many Inuit babies, who have a higher risk of infection, are not getting it.
There have been many advances made in the prevention and treatment of pneumonia, but providing for people’s basic needs can help reduce the disease burden.
Researchers from Vanderbilt University have discovered a new method of vaccination where tiny gold particles target immune…
Top contributors
-
Assistant Professor of Epidemiology, University of San Francisco
-
Associate Professor of Paediatric Infectious Diseases, University of Southampton
-
Emeritus Professor, Zoology, University of British Columbia
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Associate Professor, Department of Geography, Environment and Geomatics, University of Guelph
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor in Health Service Operations, University of Bradford
-
Practice Pharmacist/Honorary Senior Research Fellow, University of Bradford
-
Principal Medical Scientist, National Institute for Communicable Diseases
-
Professor, Great Lakes Institute for Environmental Research, School of the Environment, University of Windsor
-
Associate Professor Pediatrics and Dalla Lana School of Public Health, Chair Indigenous Health Conference, North American Refugee Health Conference, University of Toronto
-
Assistant Professor, Department of Psychology, University of Manitoba
-
Assistant Professor of Epidemiology, Texas A&M University
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Assistant Professor, Faculty of Nursing, University of Calgary
-
Research Fellow in Virology, University of Leeds
